|
LOC723972 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.254100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.277700E-02 |
| Normal-vs-Stage2 |
2.732200E-02 |
| Normal-vs-Stage3 |
4.260800E-01 |
| Normal-vs-Stage4 |
2.325000E-01 |
| Stage1-vs-Stage2 |
3.959800E-01 |
| Stage1-vs-Stage3 |
3.275800E-01 |
| Stage1-vs-Stage4 |
9.666400E-01 |
| Stage2-vs-Stage3 |
1.781220E-01 |
| Stage2-vs-Stage4 |
6.393600E-01 |
| Stage3-vs-Stage4 |
5.633200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.865800E-02 |
| Normal-vs-AfricanAmerican |
3.205800E-01 |
| Normal-vs-Asian |
1.629180E-01 |
| Caucasian-vs-AfricanAmerican |
2.408800E-01 |
| Caucasian-vs-Asian |
4.818400E-01 |
| AfricanAmerican-vs-Asian |
3.363600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.429900E-02 |
| Normal-vs-Female |
1.641440E-01 |
| Male-vs-Female |
4.329200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.830400E-01 |
| Normal-vs-Extreme_Weight |
3.353800E-02 |
| Normal-vs-Obese |
5.755500E-02 |
| Normal-vs-Extreme_Obese |
3.485400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.912800E-01 |
| Normal_Weight-vs-Obese |
3.172800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.474200E-01 |
| Extreme_Weight-vs-Obese |
9.272400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.090800E-01 |
| Obese-vs-Extreme_Obese |
8.280400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.771440E-01 |
| Normal-vs-Age(41-60Yrs) |
1.327840E-01 |
| Normal-vs-Age(61-80Yrs) |
3.951900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.802590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.769600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.951600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.351400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.757800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.551000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.088600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.541600E-02 |
| Normal-VS-Type2 PRCC |
1.430240E-01 |
| Normal-VS-KIRP CIMP |
1.261730E-02 |
| Normal-VS-Unclassified PRCC |
9.357700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.941000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.536980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.511400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.026840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.713800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.685200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.119400E-03 |
| Normal-vs-N1 |
8.985400E-01 |
| Normal-vs-N2 |
2.417200E-01 |
| N0-vs-N1 |
1.274180E-02 |
| N0-vs-N2 |
8.696200E-01 |
| N1-vs-N2 |
2.711400E-01 |
|
|
